Arkolith/Insider Trading/TBPH/Form 4

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRSTheravance Biopharma, Inc. (TBPH) · full profile →Form 4 · filed Dec 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$583K
Net Open-Market Flow
-$583K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 3, 2025Sell(S)8K$18.75$146K293K
Dec 3, 2025Sell(S)8K$18.75$146K301K
Dec 3, 2025Sell(S)16K$18.75$291K278K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001898490-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML